Aspire Biopharma Holdings, Inc. — filings

CIK 1847345

Aggregates

computed from the filings below
Documents on record
7
Form types used
2
Filed in last 12 months
7
Median interval
20 d
between consecutive filings
Most used form
8-K
6 filings
Most recent filing
2026-09-29
Filed on a Friday
0
of the filings shown
Earliest shown
2026-07-20

By form type

FormFilingsMost recent
8-K62026-09-29
10-Q12026-08-13

Documents

7 most recent shown
FiledFormAccessionSource
2026-09-298-K0001493152-26-044908document
2026-09-098-K0001493152-26-041918document
2026-09-088-K0001493152-26-041725document
2026-08-198-K0001493152-26-039135document
2026-08-1310-Q0001493152-26-037819document
2026-08-108-K0001493152-26-036777document
2026-07-208-K0001493152-26-033942document

Source: U.S. Securities and Exchange Commission, EDGAR

Aspire Biopharma Holdings, Inc. filings — 7 documents on record — investment.com